Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives - Takeaways - MDSpire

Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives

  • By

  • Medha Karnik

  • Preethi G. Anantharaju

  • Arati Sharma

  • Olga Sukocheva

  • Edmund Tse

  • SubbaRao V. Madhunapantula

  • July 3, 2026

  • 0 min

Share

  • 1

    Aurora kinase B (AURKB) is crucial for chromosome regulation and its dysregulation leads to chromosomal instability in cervical cancer.

  • 2

    High-risk HPV types, particularly HPV16 and HPV18, initiate cervical cancer by disrupting tumor suppressor pathways through E6 and E7 oncoproteins.

  • 3

    AURKB overexpression in cervical cancer correlates with tumor stage, therapeutic resistance, and poor prognosis.

  • 4

    Pharmacological inhibition of AURKB has shown promise in preclinical studies by suppressing tumor cell proliferation and enhancing treatment sensitivity.

  • 5

    AURKB is positioned as a potential therapeutic target and biomarker for aggressive cervical cancer, warranting further clinical evaluation.

Original Source(s)

Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives

  • by Medha Karnik, Preethi G. Anantharaju, Arati Sharma, Olga Sukocheva, Edmund Tse, SubbaRao V. Madhunapantula

  • July 3, 2026

Related Content

Transrectal vs. transvaginal oocyte retrieval in patients requesting egg freezing for fertility preservation: a prospective observational study

Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing

Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cells